Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,609.00
+40.70 (2.60%)
Jul 24, 2026, 3:30 PM IST
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 864.42 billion as of July 24, 2026. Its market cap has increased by 94.69% in one year.
Market Cap
864.42B
Enterprise Value
889.78B
Revenue
72.70B
Ranking
n/a
PE Ratio
79.16
Stock Price
1,609.00
ChartMarket Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 864.42B, an increase of 1,722.21%. That is a compound annual growth rate of 35.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 864.42B | 44.51% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.92T |
| Cipla | 1.14T |
| Zydus Lifesciences | 1.11T |
| Mankind Pharma | 1.04T |
| Aurobindo Pharma | 881.48B |
| Alkem Laboratories | 673.48B |
| Glenmark Pharmaceuticals | 618.58B |
| Ipca Laboratories | 447.20B |